Evidence map›Paper›PMID 36798157›Full record

ArticlebioRxiv : the preprint server for biology2024

Late-life isoleucine restriction promotes physiological and molecular signatures of healthy aging.

Chung-Yang Yeh, Lucas C S Chini, Jessica W Davidson, Gonzalo G Garcia, Meredith S Gallagher, Isaac T Freichels, Mariah F Calubag, Allison C Rodgers, Cara L Green, Reji Babygirija and 7 more

Registry-linked trialOpen access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07329088 (ISOLeucine Addition Treatment Effects), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07329088 nawithdrawnnot on this mapstarted 2026, after this paper: background citation

ISOLeucine Addition Treatment Effects (ISOLATE) in a Controlled Diet Study

TypeinterventionalSponsorJean L. FryRan2026 to 2029Enrolled0ConditionsPrediabetes (Insulin Resistance, Impaired Glucose Tolerance), Metabolic Syndrome (MetS), Obesity & OverweightArmsL-Isoleucine, Low-isoleucine diet
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 9 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Chung-Yang YehDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Lucas C S ChiniDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Jessica W DavidsonDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Gonzalo G GarciaDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109.
Meredith S GallagherDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Isaac T FreichelsDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Mariah F CalubagDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Allison C RodgersDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Cara L GreenDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Reji BabygirijaDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Michelle M SonsallaDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Heidi H PakDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Michaela TrautmanDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Timothy A HackerDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.
Richard A MillerDepartment of Pathology, University of Michigan School of Medicine, Ann Arbor, MI 48109.
Judith SimcoxDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706.
Dudley W LammingDepartment of Medicine, University of Wisconsin-Madison, Madison, WI 53705.ORCID 0000-0002-0079-4467
University of Wisconsin–Madison · USUniversity of Michigan · USHoward Hughes Medical Institute · US

Funding

Biology of Aging and Age-Related Diseases Training GrantT32AG000213 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Rozalyn M. Anderson, Sanjay Asthana · 1991 to 2026
$9.9M
The regulation of health and longevity by branched-chain amino acidsR01AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Dudley William Lamming · 2018 to 2026
$3.1M
The regulation of cancer and aging by methionineR01AG084156 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI VINCENT L. CRYNS, JOHN M DENU · 2023 to 2026
$2.5M
The regulation of health and longevity by branched-chain amino acidsRF1AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2023 to 2023
$2.1M
Comparative analysis of geroprotective interventions in established and novel mouse models of Alzheimer's diseaseR01AG062328 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM, MERRINS, MATTHEW J. · 2018 to 2022
$2.0M
Safer mTOR inhibition for human geroprotectionU01AG081482 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Adam R Konopka, Dudley William Lamming · 2023 to 2026
$1.8M
Dietary regulation of the hepatic epigenomeR01DK125859 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI DENU, JOHN M, LAMMING, DUDLEY WILLIAM · 2021 to 2023
$1.8M
Discovery and characterization of a novel acylcarnitine transporter in brown adipocytesR01DK133479 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI Judith Anne Simcox · 2022 to 2026
$1.5M
The regulation of health and longevity by branched-chain amino acidsR56AG056771 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI LAMMING, DUDLEY WILLIAM · 2017 to 2017
$573k
Regulation of cellular senescence and metabolic health by dietary proteinF31AG082504 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI CALUBAG, MARIAH · 2023 to 2025
$146k
Dietary Interventions in Alzheimer’s DiseaseF31AG081115 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI BABYGIRIJA, REJI · 2023 to 2024
$102k
Investigating Mechanisms of Isoleucine Restriction as an Effective Geroprotective InterventionsF32AG077916 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI YEH, CHUNG-YANG · 2022 to 2023
$102k
BLRD VA I01 BX004031BLRD VA IS1 BX005524NIA NIH HHS F31 AG066311NIA NIH HHS F31 AG081115NIA NIH HHS F31 AG082504NIA NIH HHS F32 AG077916NIA NIH HHS F99 AG083290NIA NIH HHS R01 AG056771NIA NIH HHS R01 AG062328NIA NIH HHS R01 AG084156NIA NIH HHS R56 AG056771NIA NIH HHS RF1 AG056771NIA NIH HHS T32 AG000213NIA NIH HHS U01 AG081482NIDDK NIH HHS R01 DK125859NIDDK NIH HHS R01 DK133479
6 · The paper itself

Abstract

In defiance of the paradigm that calories from all sources are equivalent, we and others have shown that dietary protein is a dominant regulator of healthy aging. The restriction of protein or the branched-chain amino acid isoleucine promotes healthspan and extends lifespan when initiated in young or adult mice. However, many interventions are less efficacious or even deleterious when initiated in aged animals. Here, we investigate the physiological, metabolic, and molecular consequences of consuming a diet with a 67% reduction of all amino acids (Low AA), or of isoleucine alone (Low Ile), in male and female C57BL/6J.Nia mice starting at 20 months of age. We find that both diet regimens effectively reduce adiposity and improve glucose tolerance, which were benefits that were not mediated by reduced calorie intake. Both diets improve specific aspects of frailty, slow multiple molecular indicators of aging rate, and rejuvenate the aging heart and liver at the molecular level. These results demonstrate that Low AA and Low Ile diets can drive youthful physiological and molecular signatures, and support the possibility that these dietary interventions could help to promote healthy aging in older adults.

Indexed as

agingBCAAdietary proteindietary restrictionisoleucinemetabolic healthprotein restriction

Identifiers

PMID36798157
PMCPMC9934591
OpenAlexW4319342428

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.